TGM2 and eosinophilic gastrointestinal disease: This pilot study demonstrated that in patients with pediatric CD and EGID, abnormal tTG-IgA and EMA-IgA antibody levels do not correlate with abnormal duodenal pathology after initiation of a GFD.